854P Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN). - Patnaik, M.M.; Sekeres, M.A.; DeZern, A.; Luger, S.; Sproat, L.; Bejar, R.; Hobbs, G.; Roboz, G.J.; Leoni, M.; Martell, B.; Padron, E. (Annals of Oncology, 2021)